Stock Events

Stock Events

Forte Biosciences 

$76.90
17
+$0.02+0.03% 20:00 Today
-$0.01-0.01%20:45After hours

Statistics

Day High
76.94
Day Low
76.87
52W High
77.2
52W Low
10.11
Volume
6,477,642
Avg. Volume
1,133,069
Mkt Cap
1.58B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

16NovExpected
Q3 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Next
Next
-6.33
-4.53
-2.73
-0.94
Expected EPS
-0.93525
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
0Revenue
-69.38MNet Income

Analyst Ratings

77.00Average Price Target
The highest estimate is 77.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
0%
Hold
100%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow FBRX. It's not an investment recommendation.
Tesla
3
TSLA
NVIDIA
3
NVDA
Eos Energy Enterprises
3
EOSE
Quantum Computing
3
QUBT

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Regeneron Pharmaceuticals
REGN
Mkt Cap82.72B
Regeneron Pharmaceuticals competes in the development of biologic drugs for skin diseases, similar to Forte Biosciences' focus on dermatology.
Abbvie
ABBV
Mkt Cap440.83B
AbbVie has a strong portfolio in dermatology, including treatments for conditions that Forte Biosciences targets.
AMGEN
AMGN
Mkt Cap224.63B
Amgen has a presence in the dermatology market, competing with Forte Biosciences in developing treatments for skin conditions.
Journey Medical
DERM
Mkt Cap189.67M
Journey Medical Corporation (formerly Dermira) focuses on dermatological conditions, directly competing with Forte Biosciences' dermatology focus.
AnaptysBio
ANAB
Mkt Cap1.73B
AnaptysBio is involved in developing therapeutic antibodies for inflammatory diseases, including dermatological conditions, making it a competitor.
Gilead Sciences
GILD
Mkt Cap171.56B
Gilead Sciences, through its acquisition of Immunomedics, competes in the biopharmaceutical space with a focus on treatments that could overlap with Forte Biosciences' interests.
Merck
MRK
Mkt Cap335.14B
Merck & Co. has a diversified portfolio that includes treatments for skin diseases, competing with Forte Biosciences in the dermatology space.
Pfizer
PFE
Mkt Cap152.69B
Pfizer has a broad range of healthcare products, including those for dermatological conditions, making it a competitor to Forte Biosciences.
Johnson & Johnson
JNJ
Mkt Cap627.42B
Johnson & Johnson, through its Janssen Pharmaceuticals segment, offers products for dermatology, competing with Forte Biosciences.
Bristol-Myers Squibb
BMY
Mkt Cap130.39B
Bristol Myers Squibb has a diverse biopharmaceutical portfolio that includes treatments for skin diseases, competing with Forte Biosciences.

About

Forte Biosciences Inc is a clinical-stage biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary anti-CD122 monoclonal antibody therapeutic candidate with potentially broad autoimmune and autoimmune-related indications. The Company is also advancing clinical development of FB102 in patient-based trials for non-segmental vitiligo and alopecia areata.
Show more...
CEO
Paul A. Wagner
Employees
23
Country
United States
ISIN
US34962G2084
WKN
000A40MGA

Listings

STU
DE
37T.STU
MU
DE
37T.MU
BOATS
BOATS
FBRX.BOATS
F
DE
37T.F

0 Comments

Share your thoughts

FAQ

What is Forte Biosciences stock price today?▼
The current price of FBRX is $76.90 USD — it has increased by +0.03% in the past 24 hours. Watch Forte Biosciences stock price performance more closely on the chart.
What is Forte Biosciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Forte Biosciences stocks are traded under the ticker FBRX.
Is Forte Biosciences stock price growing?▼
FBRX stock has risen by +0.16% compared to the previous week, the month change is a +57.39% rise, over the last year Forte Biosciences has showed a +554.47% increase.
What is Forte Biosciences market cap?▼
Today Forte Biosciences has the market capitalization of 1.58B
When is the next Forte Biosciences earnings date?▼
Forte Biosciences is going to release the next earnings report on November 16, 2026.
What is Forte Biosciences revenue for the last year?▼
Forte Biosciences revenue for the last year amounts to 0 USD.
What is Forte Biosciences net income for the last year?▼
FBRX net income for the last year is -69.38M USD.
How many employees does Forte Biosciences have?▼
As of August 19, 2026, the company has 23 employees.
In which sector is Forte Biosciences located?▼
Forte Biosciences operates in the Health & Wellness sector.
When did Forte Biosciences complete a stock split?▼
The last stock split for Forte Biosciences was on August 28, 2024 with a ratio of 1:25.
Where is Forte Biosciences headquartered?▼
Forte Biosciences is headquartered in DALLAS, United States.